Colony Group LLC United Therapeutics Corp Transaction History

Colony Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 18, 2020	SELL	$78.31 - $95.34 $196,636 - $239,398	-2,511 Closed	0 $0
Q3 2019 Nov 26, 2019	SELL	$74.85 - $85.99 $111,451 - $128,039	-1,489 Reduced 37.23%	2,511 $200,000
Q2 2019 Aug 19, 2019	SELL	$76.06 - $120.81 $61,152 - $97,131	-804 Reduced 16.74%	4,000 $312,000
Q2 2018 Aug 15, 2018	SELL	$101.14 - $118.31 $4.13 Million - $4.83 Million	-40,822 Reduced 89.47%	4,804 $544,000
Q1 2018 May 15, 2018	BUY	$107.21 - $151.94 $4.89 Million - $6.93 Million	45,626 New	45,626 $5.13 Million

672

42.4M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.5B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Colony Group LLC, based on Form 13F filings with the SEC.

Stay updated on Colony Group LLC with notifications on news.